Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosis

Area of Science:

• Cellular signaling
• Molecular biology
• Signal transduction

Background:

• The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK1/2) pathway is crucial for cellular processes.
• Spatiotemporal regulation of this pathway is complex and not fully understood.
• Understanding MEK2 localization provides insights into MAPK/ERK signaling dynamics.

Purpose of the Study:

• To investigate the spatiotemporal dynamics of MEK2 in living cells.
• To determine the role of endocytosis in MAPK/ERK signaling regulation.
• To elucidate the relationship between MEK2 localization and upstream signaling complexes.

Main Methods:

• Generated a HeLa cell line with RNA interference-mediated knockdown of MEK2 and stable expression of GFP-tagged MEK2.
• Utilized EGF receptor (EGFR) activation to study MEK2 translocation.
• Employed small interfering RNA (siRNA) to deplete clathrin and RAF kinases.
• Used the MEK1/2 inhibitor UO126.

Main Results:

• MEK2-GFP translocated to the plasma membrane and subsequently to early and late endosomes upon EGFR activation.
• Activated MEK was detected only at the plasma membrane, not in endosomes.
• Endosomal MEK2-GFP was separated from active EGFR.
• Clathrin knockdown abolished MEK2 endosomal recruitment but increased ERK activation.
• RAF kinase depletion and UO126 treatment blocked MEK2-GFP endosomal accumulation.

Conclusions:

• Endocytosis-mediated recruitment of MEK2 to endosomes is a novel regulatory mechanism.
• This process may represent a negative feedback loop in EGFR-MAPK signaling.
• Separation of MEK2 from upstream signaling complexes in endosomes suggests compartmentalization of signaling events.